Cryogenic Biobanking Services
Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between molecular and clinical information, providing imperative resources for researchers and companies to conduct clinical trials. Still, some biobanking companies are concerned regarding whether or not they can secure financing. Over the five years to 2018, industry revenue is expected to have increased only slightly. As many cryogenic biobanks attempt to expand their repository of biospecimens from healthy donors, however, repositories are expected to increase. More importantly, downstream researchers will increasingly require high-quality and annotated biospecimens for general and specific disease-related research.
This industry operates cryogenic storage facilities used to archive biological samples used for research. Biobanks, or repositories that store these biological samples, are used in hospitals, universities, nonprofit organizations and pharmaceutical companies.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.